Research to Advance Vaccine Safety Program

by: Iola Bonggay

The Centers for Disease Control and Prevention, more commonly referred to as CDC, is a United States federal agency operating within the Department of Health and Human Services that is primarily responsible for safeguarding public health and safety by way of providing essential health-related information and forming partnerships with state health department and several other organizations.

The programs and activities that are launched by the CDC are in accordance to their agency mission, which is to "Collaborate to create the expertise, information, and tools that people and communities need to protect their health – through health promotion, prevention of disease, injury and disability, and preparedness for new health threats."

In keeping with this mission, the Centers for Disease Control and Prevention has partnered with the National Institutes of Health and as a result, has developed the Research to Advance Vaccine Safety Program, wherein it seeks to obtain a more thorough understanding vaccine safety.

The discovery of vaccines is considered as a great medical breakthrough as it has contributed to the successful eradication of naturally occurred smallpox, and a substantial reduction of certain disease conditions that are caused by measles, mumps, influenza, hepatitis, diphtheria, and several other infections.

The Research to Advance Vaccine Safety Program aims to boost this medical breakthrough by funding scientific studies that address potentially relevant vaccine safety concerns such as:

1) A human being's immunological and physiological responses to vaccine and vaccine components.

  (continued...)

Research to Advance Vaccine Safety Program
  Page 2

About The Author Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. She also maintains Websites providing resources on grants for youth programs and home improvement grants.

Additional Resources

category - Health Grants

Identifying Heart, Lung, and Blood Disease-Causing Variants
The National Institutes of Health has formed a partnership with the National Heart, Lung, and Blood Institute to establish a program that aims to Identify Heart, Lung, and Blood Disease-Causing Variants.

---

Small Business Innovation Research Phase IIB Bridge Awards
In line with this mission, the NIH has recently constituted the Small Business Innovation Research Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization Program.

---

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

HIV Innovations for Improved Patient Outcomes for Priority Populations Program
The United States Agency for International Development in South Africa has recently established the HIV Innovations for Improved Patient Outcomes for Priority Populations Program wherein it intends to solicit applications coming from local organizations which are interested in heading the implementation of a five-year plan centered on the program in focus.

---